Joshua Bauml, MD (@jbauml) 's Twitter Profile
Joshua Bauml, MD

@jbauml

R&D at J&J Innovative Medicine. Medical oncologist. Views mine. Tweets are not medical advice. (He/him/his)

ID: 284801219

calendar_today20-04-2011 00:29:35

3,3K Tweet

5,5K Takipçi

1,1K Takip Edilen

Joshua Bauml, MD (@jbauml) 's Twitter Profile Photo
Joshua Bauml, MD
@jbauml

5 years ago

Figuring out IO approaches for patients that experience disease progression on checkpoint inhibitors remains one of the most critical questions in modern oncology. This trial presented by Joel W. Neal, MD, PhD evaluates the multikinase inhibitor cabozantinib with atezo here #WCLC20 #LCSM

Figuring out IO approaches for patients that experience disease progression on checkpoint inhibitors remains one of the most critical questions in modern oncology. This trial presented by <a href="/JoelNealMD/">Joel W. Neal, MD, PhD</a> evaluates the multikinase inhibitor cabozantinib with atezo here #WCLC20 #LCSM